2-Chloro-4-methoxythieno[3,2-d]pyrimidine, 97.0%, 250mg

Methyl 5-bromo-2-(methylsulfanyl)-4-pyrimidinecarboxylate, 95.0%, 100g

(R)-benzyl (1-(4-((1H-pyrrolo[2,3-b]pyridin-4-yl)carbamoyl)phenyl)ethyl)carbamate, 97%, 100mg

ROTI® SampleLyse Hard Tissue, 6 pcs 6 pcs

Triacetoxymanganese dihydrate, 95.0%, 500g

ethyl 2-(1-{[1-(2-ethoxy-2-oxoethyl)cyclopropyl]amino}cyclopropyl)acetate, 95.0%, 250mg

1-(2-Chloroethyl)-3-(2,4-dimethylphenyl)urea, 95+%, 1g

4-isopropyl-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg

2-Benzylidenecyclohexanone>95.0%(GC)1g

1-((1S,2S)-1-Hydroxy-1-(4-hydroxyphenyl)propan-2-yl)-4-phenylpiperidin-4-ol, 95.0%, 5mg

6-(Cyclobutylamino)pyrimidine-4-carboxylic acid, 1g

Dimethyl 4-amino-3-nitrophthalate, 95+%, 1g